Share Price and Basic Stock Data
Last Updated: January 6, 2026, 6:33 pm
| PEG Ratio | 1.85 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Bombay Super Hybrid Seeds Ltd operates within the agricultural products industry, focusing on hybrid seeds. The company’s stock price stood at ₹107, with a market capitalization of ₹1,124 Cr. Over the fiscal years, the company demonstrated a solid upward trend in revenue, with reported sales of ₹228 Cr for the year ending March 2023, rising to ₹256 Cr in March 2024, and projected at ₹358 Cr for March 2025. This represents a consistent growth trajectory, underpinned by a strategic focus on expanding product offerings and market reach. Quarterly sales figures also indicated fluctuations, with a peak of ₹156.77 Cr recorded in June 2024, suggesting seasonal demand variations. As of September 2023, sales were ₹33.76 Cr, showing a decline from the preceding quarter, but the overall trend remains positive with a trailing twelve-month sales figure of ₹354 Cr. This growth is critical in establishing the company’s position in the competitive agricultural sector, where demand for innovative seed technology is rising.
Profitability and Efficiency Metrics
The profitability metrics of Bombay Super Hybrid Seeds Ltd reflect a healthy operational performance. The company’s operating profit margin (OPM) stood at 15.46%, indicating effective cost management and operational efficiency. The reported net profit for the year ending March 2023 was ₹17 Cr, which increased to ₹22 Cr in March 2024, and is expected to reach ₹26 Cr in March 2025. The return on equity (ROE) was reported at 28.8%, showcasing superior shareholder returns compared to industry norms, while the return on capital employed (ROCE) was recorded at 21.2%, demonstrating effective utilization of capital. The interest coverage ratio (ICR) stood at 5.78 times, indicating the company’s robust ability to meet interest obligations. However, the cash conversion cycle (CCC) of 335 days points to potential inefficiencies in managing working capital, with high inventory days reported at 349, necessitating a closer examination of inventory management strategies.
Balance Sheet Strength and Financial Ratios
The balance sheet of Bombay Super Hybrid Seeds Ltd exhibits a solid financial position, with total assets reported at ₹222 Cr as of March 2025. The company’s reserves have steadily increased, reaching ₹109 Cr by September 2025, while borrowings were recorded at ₹30 Cr, indicating a manageable debt level. The debt-to-equity ratio stood at 0.88, suggesting a moderate leverage position. The price-to-book value (P/BV) ratio was reported at 12.12x, indicating a relatively high market valuation compared to its book value, reflecting investor confidence in future growth prospects. The company’s current ratio of 1.83 indicates adequate liquidity to cover short-term obligations. However, the quick ratio of 0.15 suggests potential challenges in meeting immediate liabilities without relying on inventory sales. Overall, the financial ratios showcase a balance between growth and financial stability, although attention is needed on liquidity management.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Bombay Super Hybrid Seeds Ltd reveals a strong promoter holding of 73.85%, which reflects significant insider confidence in the company’s future. The number of shareholders increased from 8,915 in December 2022 to 16,915 by September 2025, highlighting growing public interest in the stock. Notably, foreign institutional investors (FIIs) have not made significant investments, standing at 0.00%, while public shareholding constituted 26.15%. This concentrated ownership structure may indicate potential risks related to liquidity in the stock, as heavy promoter control could lead to limited free float. However, the steady increase in the number of shareholders suggests a positive sentiment among retail investors. The absence of dividend payouts, consistent since March 2015, may lead to concerns regarding shareholder returns, although reinvestment in growth initiatives could be seen as a strategic move.
Outlook, Risks, and Final Insight
Looking ahead, Bombay Super Hybrid Seeds Ltd is positioned to capitalize on the growing demand for hybrid seeds, supported by increasing agricultural productivity needs. However, the company faces risks including potential fluctuations in raw material costs and regulatory challenges in the agricultural sector. Additionally, the high cash conversion cycle indicates a need for improved inventory management, which could impact liquidity. If the company can effectively manage these risks while leveraging its operational strengths, it may continue to deliver robust growth. The focus on expanding its product portfolio and enhancing operational efficiencies will be crucial in maintaining competitive advantage. Overall, while the growth outlook remains promising, stakeholders should remain vigilant regarding external pressures and internal operational challenges that could impact financial performance in the coming periods.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| GRM Overseas Ltd | 3,184 Cr. | 173 | 186/58.6 | 60.2 | 23.5 | 0.00 % | 12.1 % | 14.6 % | 2.00 |
| Freshtrop Fruits Ltd | 129 Cr. | 162 | 179/105 | 165 | 0.00 % | 7.35 % | 8.07 % | 10.0 | |
| City Crops Agro Ltd | 30.7 Cr. | 18.8 | 28.8/17.0 | 15.8 | 0.00 % | 8.46 % | 8.14 % | 10.0 | |
| Chamanlal Setia Exports Ltd | 1,334 Cr. | 268 | 417/242 | 14.2 | 153 | 0.92 % | 16.7 % | 14.2 % | 2.00 |
| Mangalam Global Enterprise Ltd | 460 Cr. | 14.0 | 18.5/11.5 | 17.6 | 6.86 | 0.07 % | 16.8 % | 14.6 % | 1.00 |
| Industry Average | 3,785.30 Cr | 245.80 | 27.47 | 106.69 | 0.33% | 11.80% | 12.33% | 4.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 21.02 | 68.96 | 35.78 | 116.67 | 33.76 | 76.34 | 30.12 | 156.77 | 28.21 | 127.86 | 45.91 | 152.94 | 26.85 |
| Expenses | 19.65 | 61.00 | 32.45 | 103.87 | 30.84 | 67.12 | 26.61 | 143.19 | 25.12 | 117.92 | 39.78 | 137.58 | 22.70 |
| Operating Profit | 1.37 | 7.96 | 3.33 | 12.80 | 2.92 | 9.22 | 3.51 | 13.58 | 3.09 | 9.94 | 6.13 | 15.36 | 4.15 |
| OPM % | 6.52% | 11.54% | 9.31% | 10.97% | 8.65% | 12.08% | 11.65% | 8.66% | 10.95% | 7.77% | 13.35% | 10.04% | 15.46% |
| Other Income | 0.07 | 0.21 | 0.37 | 0.03 | 0.07 | 0.14 | 0.75 | 0.29 | 1.07 | 0.73 | 0.70 | 0.16 | 0.04 |
| Interest | 0.19 | 0.73 | 1.38 | 1.25 | 0.88 | 0.99 | 1.45 | 1.56 | 1.37 | 1.32 | 1.91 | 1.97 | 1.40 |
| Depreciation | 0.29 | 0.35 | 0.36 | 0.37 | 0.37 | 0.38 | 0.22 | 0.38 | 0.37 | 0.21 | 0.34 | 0.36 | 0.40 |
| Profit before tax | 0.96 | 7.09 | 1.96 | 11.21 | 1.74 | 7.99 | 2.59 | 11.93 | 2.42 | 9.14 | 4.58 | 13.19 | 2.39 |
| Tax % | 10.42% | 6.21% | 2.55% | 5.17% | 9.77% | 13.89% | -20.85% | 6.79% | 14.88% | 1.42% | 7.86% | 6.97% | 6.28% |
| Net Profit | 0.86 | 6.65 | 1.91 | 10.64 | 1.57 | 6.88 | 3.13 | 11.12 | 2.07 | 9.00 | 4.22 | 12.27 | 2.24 |
| EPS in Rs | 0.08 | 0.63 | 0.18 | 1.01 | 0.15 | 0.66 | 0.30 | 1.06 | 0.20 | 0.86 | 0.40 | 1.17 | 0.21 |
Last Updated: January 2, 2026, 5:01 am
Below is a detailed analysis of the quarterly data for Bombay Super Hybrid Seeds Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 26.85 Cr.. The value appears to be declining and may need further review. It has decreased from 152.94 Cr. (Jun 2025) to 26.85 Cr., marking a decrease of 126.09 Cr..
- For Expenses, as of Sep 2025, the value is 22.70 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 137.58 Cr. (Jun 2025) to 22.70 Cr., marking a decrease of 114.88 Cr..
- For Operating Profit, as of Sep 2025, the value is 4.15 Cr.. The value appears to be declining and may need further review. It has decreased from 15.36 Cr. (Jun 2025) to 4.15 Cr., marking a decrease of 11.21 Cr..
- For OPM %, as of Sep 2025, the value is 15.46%. The value appears strong and on an upward trend. It has increased from 10.04% (Jun 2025) to 15.46%, marking an increase of 5.42%.
- For Other Income, as of Sep 2025, the value is 0.04 Cr.. The value appears to be declining and may need further review. It has decreased from 0.16 Cr. (Jun 2025) to 0.04 Cr., marking a decrease of 0.12 Cr..
- For Interest, as of Sep 2025, the value is 1.40 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.97 Cr. (Jun 2025) to 1.40 Cr., marking a decrease of 0.57 Cr..
- For Depreciation, as of Sep 2025, the value is 0.40 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.36 Cr. (Jun 2025) to 0.40 Cr., marking an increase of 0.04 Cr..
- For Profit before tax, as of Sep 2025, the value is 2.39 Cr.. The value appears to be declining and may need further review. It has decreased from 13.19 Cr. (Jun 2025) to 2.39 Cr., marking a decrease of 10.80 Cr..
- For Tax %, as of Sep 2025, the value is 6.28%. The value appears to be improving (decreasing) as expected. It has decreased from 6.97% (Jun 2025) to 6.28%, marking a decrease of 0.69%.
- For Net Profit, as of Sep 2025, the value is 2.24 Cr.. The value appears to be declining and may need further review. It has decreased from 12.27 Cr. (Jun 2025) to 2.24 Cr., marking a decrease of 10.03 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.21. The value appears to be declining and may need further review. It has decreased from 1.17 (Jun 2025) to 0.21, marking a decrease of 0.96.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:32 am
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 31 | 63 | 110 | 82 | 75 | 103 | 171 | 191 | 228 | 256 | 358 | 354 |
| Expenses | 30 | 62 | 108 | 79 | 70 | 97 | 162 | 178 | 206 | 228 | 325 | 318 |
| Operating Profit | 1 | 1 | 1 | 3 | 4 | 6 | 9 | 14 | 22 | 28 | 33 | 36 |
| OPM % | 3% | 2% | 1% | 4% | 6% | 6% | 5% | 7% | 9% | 11% | 9% | 10% |
| Other Income | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 3 | 2 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 5 | 6 | 7 |
| Depreciation | 0 | 0 | 0 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 0 | 0 | 1 | 2 | 3 | 3 | 6 | 11 | 18 | 24 | 28 | 29 |
| Tax % | 62% | 37% | 34% | 35% | 26% | 23% | 5% | 5% | 6% | 6% | 6% | |
| Net Profit | 0 | 0 | 1 | 1 | 2 | 3 | 6 | 10 | 17 | 22 | 26 | 28 |
| EPS in Rs | 0.01 | 0.05 | 0.16 | 0.15 | 0.20 | 0.25 | 0.55 | 1.00 | 1.60 | 2.12 | 2.52 | 2.64 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 100.00% | 50.00% | 100.00% | 66.67% | 70.00% | 29.41% | 18.18% |
| Change in YoY Net Profit Growth (%) | 0.00% | 100.00% | -50.00% | 50.00% | -33.33% | 3.33% | -40.59% | -11.23% |
Bombay Super Hybrid Seeds Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2017-2018 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 28% |
| 3 Years: | 23% |
| TTM: | 20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 91% |
| 5 Years: | 58% |
| 3 Years: | 36% |
| TTM: | 21% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 71% |
| 3 Years: | 37% |
| 1 Year: | -26% |
| Return on Equity | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 31% |
| 3 Years: | 32% |
| Last Year: | 29% |
Last Updated: September 5, 2025, 1:15 am
Balance Sheet
Last Updated: December 4, 2025, 1:04 am
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2 | 3 | 3 | 5 | 7 | 8 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 0 | 0 | 1 | 3 | 14 | 15 | 18 | 29 | 46 | 68 | 94 | 109 |
| Borrowings | 6 | 7 | 12 | 16 | 13 | 16 | 30 | 39 | 53 | 48 | 92 | 30 |
| Other Liabilities | 1 | 4 | 4 | 7 | 4 | 8 | 13 | 19 | 24 | 36 | 25 | 14 |
| Total Liabilities | 8 | 15 | 20 | 31 | 38 | 47 | 73 | 98 | 133 | 162 | 222 | 163 |
| Fixed Assets | 2 | 3 | 5 | 4 | 9 | 9 | 8 | 7 | 9 | 7 | 9 | 11 |
| CWIP | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Other Assets | 7 | 12 | 15 | 24 | 29 | 38 | 64 | 91 | 124 | 155 | 213 | 151 |
| Total Assets | 8 | 15 | 20 | 31 | 38 | 47 | 73 | 98 | 133 | 162 | 222 | 163 |
Below is a detailed analysis of the balance sheet data for Bombay Super Hybrid Seeds Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 10.00 Cr..
- For Reserves, as of Sep 2025, the value is 109.00 Cr.. The value appears strong and on an upward trend. It has increased from 94.00 Cr. (Mar 2025) to 109.00 Cr., marking an increase of 15.00 Cr..
- For Borrowings, as of Sep 2025, the value is 30.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 92.00 Cr. (Mar 2025) to 30.00 Cr., marking a decrease of 62.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 14.00 Cr.. The value appears to be improving (decreasing). It has decreased from 25.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 11.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 163.00 Cr.. The value appears to be improving (decreasing). It has decreased from 222.00 Cr. (Mar 2025) to 163.00 Cr., marking a decrease of 59.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 9.00 Cr. (Mar 2025) to 11.00 Cr., marking an increase of 2.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 1.00 Cr., marking an increase of 1.00 Cr..
- For Other Assets, as of Sep 2025, the value is 151.00 Cr.. The value appears to be declining and may need further review. It has decreased from 213.00 Cr. (Mar 2025) to 151.00 Cr., marking a decrease of 62.00 Cr..
- For Total Assets, as of Sep 2025, the value is 163.00 Cr.. The value appears to be declining and may need further review. It has decreased from 222.00 Cr. (Mar 2025) to 163.00 Cr., marking a decrease of 59.00 Cr..
Notably, the Reserves (109.00 Cr.) exceed the Borrowings (30.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -5.00 | -6.00 | -11.00 | -13.00 | -9.00 | -10.00 | -21.00 | -25.00 | -31.00 | -20.00 | -59.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 17 | 15 | 12 | 19 | 15 | 25 | 16 | 31 | 14 | 14 | 7 |
| Inventory Days | 55 | 50 | 30 | 71 | 143 | 121 | 169 | 281 | 497 | 406 | 349 |
| Days Payable | 3 | 12 | 8 | 13 | 5 | 6 | 7 | 30 | 51 | 27 | 22 |
| Cash Conversion Cycle | 70 | 52 | 34 | 76 | 152 | 140 | 179 | 282 | 460 | 393 | 335 |
| Working Capital Days | 12 | 11 | 11 | 35 | 69 | 61 | 39 | 63 | 77 | 102 | 98 |
| ROCE % | 10% | 15% | 14% | 13% | 13% | 15% | 19% | 22% | 24% | 21% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 2.52 | 2.10 | 1.61 | 10.06 | 5.33 |
| Diluted EPS (Rs.) | 2.52 | 2.10 | 1.61 | 10.06 | 5.33 |
| Cash EPS (Rs.) | 2.64 | 2.25 | 1.73 | 11.26 | 7.12 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 9.98 | 7.46 | 5.37 | 37.63 | 27.57 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 9.98 | 7.46 | 5.37 | 37.63 | 27.57 |
| Revenue From Operations / Share (Rs.) | 34.19 | 24.48 | 21.72 | 184.68 | 163.28 |
| PBDIT / Share (Rs.) | 3.38 | 2.81 | 2.12 | 13.56 | 8.66 |
| PBIT / Share (Rs.) | 3.26 | 2.68 | 1.99 | 12.31 | 7.07 |
| PBT / Share (Rs.) | 2.67 | 2.24 | 1.70 | 10.51 | 5.82 |
| Net Profit / Share (Rs.) | 2.52 | 2.12 | 1.60 | 10.01 | 5.53 |
| PBDIT Margin (%) | 9.89 | 11.46 | 9.74 | 7.34 | 5.30 |
| PBIT Margin (%) | 9.53 | 10.93 | 9.15 | 6.66 | 4.32 |
| PBT Margin (%) | 7.82 | 9.15 | 7.82 | 5.68 | 3.56 |
| Net Profit Margin (%) | 7.36 | 8.64 | 7.36 | 5.41 | 3.38 |
| Return on Networth / Equity (%) | 25.22 | 28.38 | 29.78 | 26.59 | 20.04 |
| Return on Capital Employeed (%) | 32.34 | 35.32 | 35.58 | 31.46 | 23.00 |
| Return On Assets (%) | 11.90 | 13.69 | 12.62 | 10.75 | 7.97 |
| Long Term Debt / Equity (X) | 0.00 | 0.01 | 0.01 | 0.00 | 0.06 |
| Total Debt / Equity (X) | 0.88 | 0.61 | 0.93 | 0.99 | 1.05 |
| Asset Turnover Ratio (%) | 1.87 | 1.74 | 1.98 | 2.27 | 2.87 |
| Current Ratio (X) | 1.83 | 1.87 | 1.67 | 1.59 | 1.58 |
| Quick Ratio (X) | 0.15 | 0.16 | 0.13 | 0.36 | 0.39 |
| Inventory Turnover Ratio (X) | 2.14 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 5.78 | 6.44 | 7.34 | 7.51 | 6.95 |
| Interest Coverage Ratio (Post Tax) (X) | 5.30 | 5.86 | 6.54 | 6.55 | 5.44 |
| Enterprise Value (Cr.) | 1360.24 | 2381.64 | 3911.29 | 451.30 | 172.02 |
| EV / Net Operating Revenue (X) | 3.79 | 9.27 | 17.16 | 2.33 | 1.00 |
| EV / EBITDA (X) | 38.30 | 80.90 | 176.14 | 31.71 | 18.93 |
| MarketCap / Net Operating Revenue (X) | 3.54 | 9.09 | 16.93 | 2.13 | 0.85 |
| Price / BV (X) | 12.12 | 29.82 | 68.49 | 10.43 | 5.07 |
| Price / Net Operating Revenue (X) | 3.54 | 9.09 | 16.93 | 2.13 | 0.85 |
| EarningsYield | 0.02 | 0.01 | 0.00 | 0.02 | 0.03 |
After reviewing the key financial ratios for Bombay Super Hybrid Seeds Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 2.52. This value is below the healthy minimum of 5. It has increased from 2.10 (Mar 24) to 2.52, marking an increase of 0.42.
- For Diluted EPS (Rs.), as of Mar 25, the value is 2.52. This value is below the healthy minimum of 5. It has increased from 2.10 (Mar 24) to 2.52, marking an increase of 0.42.
- For Cash EPS (Rs.), as of Mar 25, the value is 2.64. This value is below the healthy minimum of 3. It has increased from 2.25 (Mar 24) to 2.64, marking an increase of 0.39.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 9.98. It has increased from 7.46 (Mar 24) to 9.98, marking an increase of 2.52.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 9.98. It has increased from 7.46 (Mar 24) to 9.98, marking an increase of 2.52.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 34.19. It has increased from 24.48 (Mar 24) to 34.19, marking an increase of 9.71.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 3.38. This value is within the healthy range. It has increased from 2.81 (Mar 24) to 3.38, marking an increase of 0.57.
- For PBIT / Share (Rs.), as of Mar 25, the value is 3.26. This value is within the healthy range. It has increased from 2.68 (Mar 24) to 3.26, marking an increase of 0.58.
- For PBT / Share (Rs.), as of Mar 25, the value is 2.67. This value is within the healthy range. It has increased from 2.24 (Mar 24) to 2.67, marking an increase of 0.43.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 2.52. This value is within the healthy range. It has increased from 2.12 (Mar 24) to 2.52, marking an increase of 0.40.
- For PBDIT Margin (%), as of Mar 25, the value is 9.89. This value is below the healthy minimum of 10. It has decreased from 11.46 (Mar 24) to 9.89, marking a decrease of 1.57.
- For PBIT Margin (%), as of Mar 25, the value is 9.53. This value is below the healthy minimum of 10. It has decreased from 10.93 (Mar 24) to 9.53, marking a decrease of 1.40.
- For PBT Margin (%), as of Mar 25, the value is 7.82. This value is below the healthy minimum of 10. It has decreased from 9.15 (Mar 24) to 7.82, marking a decrease of 1.33.
- For Net Profit Margin (%), as of Mar 25, the value is 7.36. This value is within the healthy range. It has decreased from 8.64 (Mar 24) to 7.36, marking a decrease of 1.28.
- For Return on Networth / Equity (%), as of Mar 25, the value is 25.22. This value is within the healthy range. It has decreased from 28.38 (Mar 24) to 25.22, marking a decrease of 3.16.
- For Return on Capital Employeed (%), as of Mar 25, the value is 32.34. This value is within the healthy range. It has decreased from 35.32 (Mar 24) to 32.34, marking a decrease of 2.98.
- For Return On Assets (%), as of Mar 25, the value is 11.90. This value is within the healthy range. It has decreased from 13.69 (Mar 24) to 11.90, marking a decrease of 1.79.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.88. This value is within the healthy range. It has increased from 0.61 (Mar 24) to 0.88, marking an increase of 0.27.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.87. It has increased from 1.74 (Mar 24) to 1.87, marking an increase of 0.13.
- For Current Ratio (X), as of Mar 25, the value is 1.83. This value is within the healthy range. It has decreased from 1.87 (Mar 24) to 1.83, marking a decrease of 0.04.
- For Quick Ratio (X), as of Mar 25, the value is 0.15. This value is below the healthy minimum of 1. It has decreased from 0.16 (Mar 24) to 0.15, marking a decrease of 0.01.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.14. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 2.14, marking an increase of 2.14.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 5.78. This value is within the healthy range. It has decreased from 6.44 (Mar 24) to 5.78, marking a decrease of 0.66.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.30. This value is within the healthy range. It has decreased from 5.86 (Mar 24) to 5.30, marking a decrease of 0.56.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,360.24. It has decreased from 2,381.64 (Mar 24) to 1,360.24, marking a decrease of 1,021.40.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.79. This value exceeds the healthy maximum of 3. It has decreased from 9.27 (Mar 24) to 3.79, marking a decrease of 5.48.
- For EV / EBITDA (X), as of Mar 25, the value is 38.30. This value exceeds the healthy maximum of 15. It has decreased from 80.90 (Mar 24) to 38.30, marking a decrease of 42.60.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.54. This value exceeds the healthy maximum of 3. It has decreased from 9.09 (Mar 24) to 3.54, marking a decrease of 5.55.
- For Price / BV (X), as of Mar 25, the value is 12.12. This value exceeds the healthy maximum of 3. It has decreased from 29.82 (Mar 24) to 12.12, marking a decrease of 17.70.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.54. This value exceeds the healthy maximum of 3. It has decreased from 9.09 (Mar 24) to 3.54, marking a decrease of 5.55.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bombay Super Hybrid Seeds Ltd:
- Net Profit Margin: 7.36%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 32.34% (Industry Average ROCE: 11.8%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 25.22% (Industry Average ROE: 12.33%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 5.3
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.15
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 39.6 (Industry average Stock P/E: 27.47)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.88
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.36%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agricultural Products | Shreenathji Industrial Estate, Plot No. 11, National Highway 8-B, Rajkot Dist. Gujarat 360023 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Arvindkumar Kakadia | Chairman & Managing Director |
| Mr. Kiritkumar Kakadia | Executive Director & CFO |
| Mr. Hemang Baxi | Executive Director |
| Mr. Kishorkumar Kakadia | Executive Director |
| Mr. Jadavjibhai Kakadia | Executive Director |
| Mr. Dharmesh Chotai | Ind. Non-Executive Director |
| Mr. Amit Gadhiya | Ind. Non-Executive Director |
| Mr. Hardik Patel | Ind. Non-Executive Director |
| Mrs. Richa Kaushal Mashru | Ind. Non-Executive Director |
| Mr. Harshil Vasani | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Bombay Super Hybrid Seeds Ltd?
Bombay Super Hybrid Seeds Ltd's intrinsic value (as of 07 January 2026) is ₹106.09 which is 1.04% higher the current market price of ₹105.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,097 Cr. market cap, FY2025-2026 high/low of ₹180/94.2, reserves of ₹109 Cr, and liabilities of ₹163 Cr.
What is the Market Cap of Bombay Super Hybrid Seeds Ltd?
The Market Cap of Bombay Super Hybrid Seeds Ltd is 1,097 Cr..
What is the current Stock Price of Bombay Super Hybrid Seeds Ltd as on 07 January 2026?
The current stock price of Bombay Super Hybrid Seeds Ltd as on 07 January 2026 is ₹105.
What is the High / Low of Bombay Super Hybrid Seeds Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Bombay Super Hybrid Seeds Ltd stocks is ₹180/94.2.
What is the Stock P/E of Bombay Super Hybrid Seeds Ltd?
The Stock P/E of Bombay Super Hybrid Seeds Ltd is 39.6.
What is the Book Value of Bombay Super Hybrid Seeds Ltd?
The Book Value of Bombay Super Hybrid Seeds Ltd is 11.4.
What is the Dividend Yield of Bombay Super Hybrid Seeds Ltd?
The Dividend Yield of Bombay Super Hybrid Seeds Ltd is 0.00 %.
What is the ROCE of Bombay Super Hybrid Seeds Ltd?
The ROCE of Bombay Super Hybrid Seeds Ltd is 21.2 %.
What is the ROE of Bombay Super Hybrid Seeds Ltd?
The ROE of Bombay Super Hybrid Seeds Ltd is 28.8 %.
What is the Face Value of Bombay Super Hybrid Seeds Ltd?
The Face Value of Bombay Super Hybrid Seeds Ltd is 1.00.